Abstract Details
|
Claudia A. Chiriboga, MD, FAAN
(Columbia University)
PRESENTER |
Dr. Chiriboga has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentec. Dr. Chiriboga has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. The institution of Dr. Chiriboga has received research support from Roche. The institution of Dr. Chiriboga has received research support from Avexis/Novartis. The institution of Dr. Chiriboga has received research support from Biogen. The institution of Dr. Chiriboga has received research support from NIH. The institution of Dr. Chiriboga has received research support from Biohaven. The institution of Dr. Chiriboga has received research support from Genentec. Dr. Chiriboga has received publishing royalties from a publication relating to health care. |
| No disclosure on file | |
| Dirk Fischer | The institution of Dirk Fischer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Hoffmann La Roche AG. The institution of Dirk Fischer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann La Roche AG. |
| Dominik Kraus | No disclosure on file |
| No disclosure on file | |
| No disclosure on file | |
| Heidemarie Kletzl | Heidemarie Kletzl has received personal compensation for serving as an employee of Hoffmann-La Roche. |
| No disclosure on file | |
| No disclosure on file | |
| No disclosure on file | |
| Ksenija Gorni | Dr. Gorni has received personal compensation for serving as an employee of Hoffman La Roche. |
| Omar Khwaja, MD | No disclosure on file |